Management of Treatment-Resistant Depression

Online

1 Hours

State:

As a Jointly Accredited Organization, NetCE is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers participating in this intermediate to advanced course will receive 1 Clinical continuing education clock hours.

4.6

Course Overview
Management of treatment-resistant depression requires a comprehensive treatment plan addressing the complex behavioral and emotional needs of the patient. Emphasis is placed on individualized, trauma-informed care that promotes stability, emotional regulation, and improved interpersonal relationships. Through a combination of therapeutic interventions—including individual and group therapy, skill development, family involvement, and ongoing assessment—the treatment approach aims to foster resilience, personal growth, and long-term success. Collaboration among care providers, consistent structure, and adaptive strategies remain central to achieving the desired therapeutic outcomes.

Learning Outcomes
Upon the completion of this course, the learner should be able to:

Outline nonpharmacologic options for the management of treatment-resistant depression.
Compare and contrast pharmacologic options for patients with poorly controlled or treatment-resistant depression.

About the Author/Presenter
Mark Rose, BS, MA, LP, is a licensed psychologist in the State of Minnesota with a private consulting practice and a medical research analyst with a biomedical communications firm. Earlier healthcare technology assessment work led to medical device and pharmaceutical sector experience in new product development involving cancer ablative devices and pain therapeutics. Along with substantial experience in addiction research, Mr. Rose has contributed to the authorship of numerous papers on CNS, oncology, and other medical disorders. He is the lead author of papers published in peer-reviewed addiction, psychiatry, and pain medicine journals and has written books on prescription opioids and alcoholism published by the Hazelden Foundation. He also serves as an Expert Advisor and Expert Witness to law firms that represent disability claimants or criminal defendants on cases related to chronic pain, psychiatric/substance use disorders, and acute pharmacologic/toxicologic effects. Mr. Rose is on the Board of Directors of the Minneapolis-based International Institute of Anti-Aging Medicine and is a member of several professional organizations.

Audience/Accreditations and Approvals
TRC Healthcare/ NetCE
In support of improving patient care, this activity has been planned and implemented by TRC Healthcare/ NetCE. TRC Healthcare/NetCE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This course is designed for the following healthcare professions (select your profession for details):
Counselor, Nursing, Physician, Psychology, Social Work

If you require special accommodations, please contact Colibri Healthcare Support by clicking here: Contact Us

Management of Treatment-Resistant Depression

4.6

Learning Outcomes
Upon the completion of this course, the learner should be able to:

Outline nonpharmacologic options for the management of treatment-resistant depression.
Compare and contrast pharmacologic options for patients with poorly controlled or treatment-resistant depression.

If you require special accommodations, please contact Colibri Healthcare Support by clicking here: Contact Us